Show Notes
๐๐ฎ๐บ๐ถ๐น๐น๐ฒ ๐ก. ๐๐ผ๐๐๐ผ๐ป (๐ง๐ง๐ฆ ๐๐ฑ๐๐ฐ๐ฎ๐๐ถ๐ผ๐ป ๐๐ต๐ฎ๐ถ๐ฟ) ๐ฎ๐ป๐ฑ ๐ฐ๐ผ-๐ต๐ผ๐๐ ๐ฆ๐๐ฒ๐ณ๐ฎ๐ป ๐. ๐ง๐๐น๐น๐ถ๐๐ (๐๐ฑ๐ถ๐๐ผ๐ฟ-๐ถ๐ป-๐๐ต๐ถ๐ฒ๐ณ, ๐๐ณ๐ข๐ฏ๐ด๐ฑ๐ญ๐ข๐ฏ๐ต๐ข๐ต๐ช๐ฐ๐ฏ ๐๐ผ๐๐ฟ๐ป๐ฎ๐น๐) ๐ด๐ฑ๐ฆ๐ข๐ฌ ๐ธ๐ช๐ต๐ฉ ๐๐ฟ๐ฎ๐ฑ๐น๐ฒ๐ ๐. ๐๐ฎ๐ฟ๐ฑ๐ถ๐ป๐ฒ๐ฟ ๐ฎ๐ฏ๐ผ๐๐ต ๐ต๐ถ๐ ๐ต๐ฆ๐ข๐ฎโ๐ด ๐ฟ๐ฒ๐ฐ๐ฒ๐ป๐๐น๐บ ๐ฝ๐๐ฏ๐น๐ถ๐๐ต๐ฒ๐ฑ ๐บ๐ฎ๐ป๐๐ด๐ฐ๐ฟ๐ถ๐ฝ๐ ๐ถ๐ป ๐๐ณ๐ข๐ฏ๐ด๐ฑ๐ญ๐ข๐ฏ๐ต๐ข๐ต๐ช๐ฐ๐ฏ: โ๐๐น๐ผ๐ฏ๐ฎ๐น ๐๐บ๐บ๐๐ป๐ฒ ๐๐ถ๐ผ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐๐ผ๐ป๐ผ๐ฟ ๐ฆ๐ฒ๐ฟ๐ผ๐๐๐ฎ๐๐๐ ๐๐ฎ๐ป ๐ฃ๐ฟ๐ฒ๐ฑ๐ถ๐ฐ๐ ๐๐๐๐ผ๐บ๐ฒ๐ด๐ฎ๐น๐ผ๐๐ถ๐ฟ๐๐ ๐๐ป๐ณ๐ฒ๐ฐ๐๐ถ๐ผ๐ป ๐ช๐ถ๐๐ต๐ถ๐ป ๐ฆ๐ฒ๐ฟ๐ผ๐ฝ๐ผ๐๐ถ๐๐ถ๐๐ฒ ๐๐๐ป๐ด ๐ง๐ฟ๐ฎ๐ป๐๐ฝ๐น๐ฎ๐ป๐ ๐ฅ๐ฒ๐ฐ๐ถ๐ฝ๐ถ๐ฒ๐ป๐๐.โ
๐ฅ๐ฒ๐ฎ๐ฑ ๐๐ต๐ฒ ๐ฎ๐ฟ๐๐ถ๐ฐ๐น๐ฒ: https://journals.lww.com/transplantjo...
๐๐ฒ๐ฎ๐ฟ๐ป๐ถ๐ป๐ด ๐ข๐ฏ๐ท๐ฒ๐ฐ๐๐ถ๐๐ฒ๐ 1. Discuss the role of immune biomarkers in predicting CMV and other infections in lung transplant recipients. 2. Explore advantages and limitations of absolute lymphocyte count (ALC) as a predictor. 3. Review data from Gardiner et al. evaluating ALC and mitogen values as predictors of CMV in R+ lung transplant recipients. 4. Highlight recent TTS CMV guidelines relevant to this topic. โ ๐๐ผ๐น๐น๐ผ๐ & ๐๐ฒ๐ฎ๐ฟ๐ป ๐ ๐ผ๐ฟ๐ฒ โข ๐ง๐ง๐ฆ: https://tts.org โข ๐ง๐ฟ๐ฎ๐ป๐๐ฝ๐น๐ฎ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ผ๐๐ฟ๐ป๐ฎ๐น๐: https://transplantjournal.com
This podcast is for educational purposes and is not a substitute for professional medical advice.
More from TTS Pulse Podcast
Original Air Date: Friday, March 14, 2025
Original Air Date: Wednesday, May 21, 2025
Original Air Date: Thursday, February 6, 2025
Original Air Date: Wednesday, March 4, 2026
Original Air Date: Wednesday, August 27, 2025